Compound Summary
Compound Name: | ML-9 |
Compound CID: | 108047 |
Synonyms: | ML-9 105637-50-1 ML-9 hydrochloride ML 9 hydrochloride ML-9 HCl More... |
Iupac Name: | 1-(5-chloronaphthalen-1-yl)sulfonyl-1,4-diazepane;hydrochloride |
InChI: | InChI=1S/C15H17ClN2O2S.ClH/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18;/h1-2,4-7,17H,3,8-11H2;1H |
InChIKey: | ZNRYCIVTNLZOGI-UHFFFAOYSA-N |
Canonical Smiles: | C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl.Cl |
Isomeric Smiles: | C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl.Cl |
Molecular Weight: | 361.3 |
Molecular Formula: | C15H18Cl2N2O2S |
Molecular Weight: | 361.3 |
Molecular Formula: | C15H18Cl2N2O2S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 22 |
Complexity: | 451 |
ML-9 | ML-9 |
---|---|
ML-9 |
105637-50-1 |
ML-9 hydrochloride |
ML 9 hydrochloride |
ML-9 HCl |
1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride |
UNII-BZ2L6JK93I |
1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine HCl |
BZ2L6JK93I |
MFCD00065525 |
1-(5-Chloronaphthalenesulfonyl)homopiperazine hydrochloride |
1-(5-chloronaphthalen-1-ylsulfonyl)-1,4-diazepane hydrochloride |
1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride |
ML 9 |
1H-1,4-Diazepine, 1-((5-chloro-1-naphthalenyl)sulfonyl)hexahydro-, monohydrochloride |
1-(5-Chloronaphthalenesulphonyl)-1H-hexahydro-1,4-diazepine hydrochloride ML-9 |
ML-9, Hydrochloride |
SR-01000075741 |
1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine |
BMK1-E7 |
1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl |
SCHEMBL1848494 |
CHEMBL1257075 |
DTXSID60147228 |
BCP34094 |
EX-A4928 |
Tox21_500209 |
NSC734549 |
s6847 |
AKOS022180145 |
ML-9, >=99% (TLC), powder |
CCG-221513 |
LP00209 |
NSC 734549 |
NSC-734549 |
VZ20991 |
NCGC00093681-01 |
NCGC00260894-01 |
LS-14401 |
DB-040642 |
HY-100932 |
B6300 |
CS-0020603 |
EU-0100209 |
FT-0642604 |
C 1172 |
K00008 |
ML-9, Hydrochloride - CAS 105637-50-1 |
A801288 |
J-001466 |
ML9 hydrochloride;ML9 HCl; ML-9 HCl; ML 9 HCl |
SR-01000075741-1 |
SR-01000075741-3 |
Q27274976 |
1-(5-chloronaphthalenesulfonyl)homo piperazine hydrochloride |
ML-9; 1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl |
1-((5-CHLORONAPHTHALEN-1-YL)SULFONYL)-1,4-DIAZEPANE HCL |
1-(5-chloronaphthalen-1-yl)sulfonyl-1,4-diazepane;hydrochloride |
1H-1,4-Diazepine,1-(5-chloro-1-naphthalenyl)sulfonylhexahydro-, hydrochloride (1:1) |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | -7.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -7.000000000000000 | 1 | 1 |